- Home
- SNGX vs CARV Comparison
SNGX vs CARV Comparison
Compare SNGX & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- CARV
- Stock Information
- Founded
- SNGX 1987
- CARV 1948
- Country
- SNGX United States
- CARV United States
- Employees
- SNGX N/A
- CARV N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- CARV Savings Institutions
- Sector
- SNGX Health Care
- CARV Finance
- Exchange
- SNGX Nasdaq
- CARV Nasdaq
- Market Cap
- SNGX 10.1M
- CARV 13.2M
- IPO Year
- SNGX 1987
- CARV 1994
- Fundamental
- Price
- SNGX $2.81
- CARV $2.35
- Analyst Decision
- SNGX Strong Buy
- CARV
- Analyst Count
- SNGX 1
- CARV 0
- Target Price
- SNGX $6.00
- CARV N/A
- AVG Volume (30 Days)
- SNGX 659.7K
- CARV 255.3K
- Earning Date
- SNGX 11-07-2025
- CARV 11-13-2025
- Dividend Yield
- SNGX N/A
- CARV N/A
- EPS Growth
- SNGX N/A
- CARV N/A
- EPS
- SNGX N/A
- CARV N/A
- Revenue
- SNGX N/A
- CARV $22,032,000.00
- Revenue This Year
- SNGX N/A
- CARV N/A
- Revenue Next Year
- SNGX N/A
- CARV N/A
- P/E Ratio
- SNGX N/A
- CARV N/A
- Revenue Growth
- SNGX N/A
- CARV N/A
- 52 Week Low
- SNGX $1.09
- CARV $1.30
- 52 Week High
- SNGX $6.23
- CARV $3.85
- Technical
- Relative Strength Index (RSI)
- SNGX 49.49
- CARV 53.46
- Support Level
- SNGX $2.58
- CARV $2.20
- Resistance Level
- SNGX $2.98
- CARV $3.85
- Average True Range (ATR)
- SNGX 0.19
- CARV 0.42
- MACD
- SNGX -0.07
- CARV -0.01
- Stochastic Oscillator
- SNGX 35.94
- CARV 30.88
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.